Hetero Healthcare Divisions
Hetero Healthcare is one of the leading manufacturers, distributors, and bulk suppliers of pharmaceutical drugs. We aim to satisfy the demand for medicines and improve the lives of many people. The specification of the "division of drugs" defines our area of emphasis for public inquiries and provides information about different Hetero Healthcare divisions. Click through your required division to view the therapies and brands associated with that particular division.
-
AURA Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to AURA Division -
Diaspa Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Diaspa Division -
Frenza Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Frenza Division -
Gastro Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Gastro Division -
Generics(Alpha) Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Generics(Alpha) Division -
Genx Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Genx Division -
HHCL Main Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to HHCL Main Division -
KRIS Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to KRIS Division -
Oncology Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Oncology Division -
Speciality Care Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Speciality Care Division -
Volga Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Volga Division -
ASRA Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to ASRA Division -
COVID 19 Management
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to COVID 19 Management -
ULTRA Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to ULTRA Division -
Sports & Wellness
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Sports & Wellness -
Healion Division
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Healion Division -
DermaGlow
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to DermaGlow -
AURUM
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to AURUM -
Synergy
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Synergy -
KRIS PLUS
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to KRIS PLUS -
Ornova
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Ornova -
Hetero Healthcare
Hetero Healthcare Ltd began its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS. We Manufacture and market major classes of ARVs as mono drugs, dual or triple-drug FDCs and differential packaging to improve patient compliance.
Go to Hetero Healthcare
